This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: August 20, 2021
Expiration Date: August 20, 2022
This enduring education is designed to help dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs to identify the signs and symptoms of atopic dermatitis in adult patients, assess disease severity, incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice, and utilize shared decision making to help individualize care.
Release Date: August 26, 2021
Expiration Date: August 26, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: August 30, 2021
Expiration Date: August 30, 2022
This enduring activity will cover early detection and intervention in prostate cancer.
Release Date: August 30, 2021
Expiration Date: August 30, 2022
This activity will explore the management of patients with newly diagnosed, relapsed/refractory, and secondary acute myeloid leukemia (AML).
Release Date: September 7, 2021
Expiration Date: September 7, 2022
This case-based activity will cover the pathophysiology, point-of-care testing, and antiviral therapy for treating patients who present to the Emergency Department.
Release Date: September 16, 2021
Expiration Date: September 16, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
Release Date: September 17, 2021
Expiration Date: September 17, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
Release Date: September 17, 2021
Expiration Date: September 17, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: September 20, 2021
Expiration Date: September 20, 2022
This enduring activity will cover the care and treatment of patients with moderate-to-severe atopic dermatitis.
Release Date: September 21, 2021
Expiration Date: September 21, 2022
This activity consists of presentations from expert faculty and 3D animation technology to discuss the pathology of small cell lung cancer (SCLC), clinical trial data of therapy in the second-line setting of SCLC, and clinical practice guidelines for the management of extensive disease.
RELEASE DATE: September 27, 2021
EXPIRATION DATE: September 27, 2022
This activity will cover the assessment, monitoring, and treatment of chronic lymphocytic leukemia (CLL) in the Department of Veterans Affairs.
Release Date: September 29, 2021
Expiration Date: September 29, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This online activity targets healthcare gaps related to the recognition, prevention, and management of diabetic retinopathy (DR). An expert panel discussion will guide you in identifying candidates for anti-VEGF therapy, review clinical trial data on the use of these agents, and provide evidence-based strategies to individualize the management of DR and overcome treatment barriers.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This activity consists of presentations from expert faculty and 2D animation technology to explain immune dysfunction and the pathogenesis of non-small cell lung cancer (NSCLC), currently available and emerging immuno-oncology used alone and in combination with chemotherapy for NSCLC, and the usefulness and application of biomarkers to guide treatment selection for NSCLC.
RELEASE DATE: October 06, 2021
EXPIRATION DATE: October 06, 2022
This enduring activity will review clinical trial data on the efficacy and safety of monoclonal antibodies and vaccines authorized for use in the treatment and prevention of COVID-19, and highlight and address healthcare disparities during the COVID-19 pandemic.
RELEASE DATE: October 08, 2021
EXPIRATION DATE: October 08, 2022
This program will explore the management of “off” episodes in patients with Parkinson’s disease. Interactive case studies presented by expert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 08, 2021
EXPIRATION DATE: October 08, 2022
This activity will cover the assessment, monitoring, and treatment of patients with severe uncontrolled asthma within the Department of Veterans Affairs.
RELEASE DATE: October 12, 2021
EXPIRATION DATE: October 12, 2022
PROGRAM CHAIR Robert Toto, MD Professor of Internal Medicine and Nephrology Director, Clinical Nephrology Director, Patient-Oriented Research in Nephrology Dallas, TX SPEAKING FACULTY Richard E. Pratley, MD Samuel E. Crockett
This case-based live-virtual activity will cover the treatment and management of patients with severe asthma.
RELEASE DATE: October 15, 2021
EXPIRATION DATE: October 15, 2022
This activity is designed to meet the educational needs of primarily dermatologists, onco-dermatologists, and also medical oncologists, Mohs surgeons, and other healthcare practitioners who care for patients with advanced/metastatic basal cell skin cancer.
RELEASE DATE: October 20, 2021
EXPIRATION DATE: October 20, 2022
This program will explore the management of off episodes in patients with Parkinson’s disease. Interactive case studies presented by ex pert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 21, 2021
EXPIRATION DATE: October 21, 2022
This live virtual symposium is focused on the team involved in the care of the people who undergo screening for cancer.
RELEASE DATE: October 22, 2021
EXPIRATION DATE: October 22, 2022
The case-based online activity will cover the treatment and management of patients with severe asthma.
RELEASE DATE: October 27, 2021
EXPIRATION DATE: October 27, 2022
This program will explore the use of systemic therapies for the management of moderate-to-severe atopic dermatitis in pediatric and adult patients.
RELEASE DATE: October 27, 2021
EXPIRATION DATE: October 27, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021
EXPIRATION DATE: October 29, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021
EXPIRATION DATE: October 29, 2022
This activity will cover the assessment, monitoring, and treatment of Acute Myeloid Leukemia (AML).
RELEASE DATE: November 12, 2021
EXPIRATION DATE: November 12, 2022
This enduring activity will cover the treatment and management of patients with moderate to severe asthma.
RELEASE DATE: November 16, 2021
EXPIRATION DATE: November 16, 2022
This activity will cover the assessment, monitoring, and treatment of patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas.
RELEASE DATE: November 16, 2021
EXPIRATION DATE: November 16, 2022
This case-based online activity will cover the treatment and management of patients with hepatocellular carcinoma (HCC).
RELEASE DATE: November 18, 2021
EXPIRATION DATE: November 18, 2022
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder.
RELEASE DATE: November 18, 2021
EXPIRATION DATE: November 18, 2022
This virtual satellite symposium discusses best practices for managing people with influenza who are at high risk for developing pulmonary complications. 2D animation technology is incorporated throughout the program to highlight the mechanism of action of point-of-care tests (POCTs) and antiviral treatments approved for treatment. Clinical data supporting the efficacy of antivirals and guidance on their use will also be provided.
RELEASE DATE: November 19, 2021
EXPIRATION DATE: November 19, 2022
In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.
RELEASE DATE: November 26, 2021
EXPIRATION DATE: November 26, 2022
The case-based online activity will cover the treatment and management of patients with chronic and diabetic kidney disease (DKD).
RELEASE DATE: November 30, 2021
EXPIRATION DATE: November 30, 2022
Upon the completion of this program, attendees should be able to:
RELEASE DATE: December 01, 2021
EXPIRATION DATE: December 01, 2022
This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.
RELEASE DATE: December 07, 2021
EXPIRATION DATE: December 07, 2022
This enduring virtual TeleECHO program will explore the management of small cell lung cancer (SCLC) in the second-line setting. A brief didactic presentation will discuss treatment options after relapse of SCLC and will assess clinical trial data regarding the efficacy and safety of second-line treatment regimens. Interactive case studies will illustrate the application of guideline recommendations for treatments approved for managing extensive-stage SCLC.
RELEASE DATE: December 07, 2021
EXPIRATION DATE: December 07, 2022
In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.
RELEASE DATE: December 21, 2021
EXPIRATION DATE: December 21, 2022
Recent advances in treatment strategies promise to improve the lives of patients with sickle cell disease or hemophilia. In this program, experts in both fields will assist clinicians in developing individualized management plans using state-of-the-art and emerging therapies, and highlight opportunities to implement multidisciplinary, patient-centered approaches to care. Case studies and interactive question and answers will provide learners practice in applying patient-specific factors to treatment decisions. This activity will feature whiteboard animations that will reinforce learning and help participants gain a higher level of understanding.
RELEASE DATE: December 21, 2021
EXPIRATION DATE: December 21, 2022
This enduring activity is a faculty-led didactic and case-based lecture focusing on the management of patients with gastric cancer and colorectal cancer.
RELEASE DATE: December 22, 2021
EXPIRATION DATE: December 22, 2022
This case-based online activity will help gynecologists and medical oncologists improve the timeliness of screening for women at risk for cervical cancer and the accuracy of diagnosis; and recognize the limitations of currently available regimens for recurrent and metastatic disease. The education will also seek to expand awareness of the integral role that the immune system plays in the pathology of cervical cancer and how IO agents in late-stage development for patients with recurrent or metastatic cervical cancer potentially could be integrated into practice once available.
RELEASE DATE: December 23, 2021
EXPIRATION DATE: December 23, 2022
This activity is designed to meet the educational needs of rheumatologists, rheumatology-related nurse practitioners, physician assistants and fellows.
RELEASE DATE: December 24, 2021
EXPIRATION DATE: December 24, 2022
RELEASE DATE: December 28, 2021
EXPIRATION DATE: December 28, 2022
This activity will explore strategies to improve glycemic and metabolic outcomes in patients with type 2 diabetes mellitus (T2DM). A review of clinical trial data will enable clinicians to personalize the selection of therapies for patients and examine the role of emerging dual GIP and GLP-1 receptor agonists in the management of type 2 diabetes and obesity.
RELEASE DATE: December 29, 2021
EXPIRATION DATE: December 29, 2022
This program is intended to help HCPs improve the diagnosis of SMA among older adolescent and adult patients and learn how the changing treatment landscape may alter patient outcomes.
RELEASE DATE: January 04, 2022
EXPIRATION DATE: January 04, 2023
This enduring activity is intended for dermatologists, pediatric dermatologists, and dermatology advanced providers (NPs and PAs) who are involved in the care and treatment of patients with alopecia areata.
RELEASE DATE: January 12, 2022
EXPIRATION DATE: January 12, 2023
RELEASE DATE: January 27, 2022
EXPIRATION DATE: January 27, 2023
This series of TeleECHO activities will discuss the management of patients with advanced and/or metastatic (m) renal cell carcinoma (RCC) and therapeutic options available in the first line setting.
RELEASE DATE: January 28, 2022
EXPIRATION DATE: January 28, 2023
RELEASE DATE: January 31, 2022
EXPIRATION DATE: January 31, 2023
This case-based online activity is designed to provide clinicians with an overview of prurigo nodularis (PN), the importance of early diagnosis, and our latest understanding of the management options for the disease.
RELEASE DATE: February 08, 2022
EXPIRATION DATE: February 08, 2023
RELEASE DATE: February 10, 2022
EXPIRATION DATE: February 10, 2023
This program will review immunotherapies for the first-line management of patients with advanced NSCLC.
RELEASE DATE: February 10, 2022
EXPIRATION DATE: February 10, 2023
RELEASE DATE: February 16, 2022
EXPIRATION DATE: February 16, 2023
This activity is designed to help lipidologists, cardiologists, and other healthcare professionals involved in the management of US veterans with familial hypercholesterolemia (FH) to improve cholesterol and cardiovascular outcomes for veteran patients.
RELEASE DATE: February 23, 2022
EXPIRATION DATE: February 23, 2023
This enduring activity is a faculty-led didactic and case-based lecture focusing on the management of patients with hepatocellular carcinoma (HCC).
RELEASE DATE: February 23, 2022
EXPIRATION DATE: February 23, 2023
This activity provides a practice-based learning experience for dermatologist and primary care physicians regarding the assessment and treatment of alopecia areata (AA). By participating in this Simulation Center, learners will observe an interaction between a physician and their patient with AA and will test their knowledge of diagnosis and management at key decision points along the way. The burden of AA and its associated comorbidities will be highlighted, and you will learn strategies to effectively address the psychosocial impacts of this disease with your patients.
RELEASE DATE: February 23, 2022
EXPIRATION DATE: February 23, 2023
This enduring activity focuses on the treatment and management of patients with generalized myasthenia gravis (gMG).
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations and case studies.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This enduring activity is designed to review early identification strategies for MS; assess the variety of treatments available to treat the condition; and discuss ways to improve adherence, engagement, and clinician/patient communication.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This activity will help participants to overcome clinical inertia and other potential barriers to timely and appropriate insulin therapy in patients with type 2 diabetes. Participants will be equipped with an enhanced ability to select, titrate and adjust basal insulin regimens, and to successfully educate and empower their patients to self-manage their diabetes.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This CME activity will help participants identify the characteristics of older adults with type 2 diabetes that require special consideration, assess older patients with type 2 diabetes, and develop personalized pharmacotherapeutic strategies for older patients with type 2 diabetes, both in the community and in long-term care, that include the use of fixed-ratio GLP-1 receptor agonist/insulin combinations. The activity features a Situation Room, a unique online program which employs a patient simulation platform. The situation room provides interactive quizzing, testing, and training via immersion-focused 3D simulations of scenarios encountered by clinicians who care for older adults with type 2 diabetes. The experience will be customized based on who is using the simulation. One track will be aimed at geriatricians and endocrinologists, and the other will be aimed at PCPs, physician extenders and consultant pharmacists. A slide presentation will guide the learners in their selection of treatment strategies.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
RELEASE DATE: February 28, 2022
EXPIRATION DATE: February 28, 2023
This enduring activity will discuss the causes of alopecia areata and how to best manage this disease. Expert faculty will highlight the burden of alopecia areata and will offer participants strategies for implementing treatment plans that will not only address the disease itself, but also the overall health challenges for this patient population.
RELEASE DATE: March 02, 2022
EXPIRATION DATE: March 02, 2023
This case-based enduring activity is designed to help community oncologists and the multidisciplinary care team choose the optimal treatment for chronic lymphocytic leukemia (CLL) based on patient and disease characteristics, including performance status, organ function, comorbidities, drug interactions, and genetic and molecular biomarkers; monitor for and manage adverse events; and implement SDM into clinical practice to improve patient care and QoL.
RELEASE DATE: March 04, 2022
EXPIRATION DATE: March 04, 2023
This enduring TeleECHO program will explore the management of patients with advanced endometrial cancer through interactive case studies. Faculty will review strategies on personalizing the selection of treatment options based on molecular testing and discuss the management of adverse events with immune-oncology/tyrosine kinase inhibitor combination therapies.
RELEASE DATE: March 04, 2022
EXPIRATION DATE: March 04, 2023
This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations, case presentations, and a pre-recorded Q&A session.
RELEASE DATE: March 09, 2022
EXPIRATION DATE: March 09, 2023
This activity will explore the management of pediatric and adult patients with moderate-to-severe atopic dermatitis through interactive case-based simulations. Expert faculty will review strategies on how to personalize the selection of systemic treatment options based on guideline recommendations, evidence-based best practice, and emerging clinical trial data. Case-based simulations will help learners identify candidates for systemic therapy and address safety and quality of life issues.
RELEASE DATE: March 11, 2022
EXPIRATION DATE: March 11, 2023
This enduring program is designed for allergists, otolaryngologists, primary care clinicians, and other clinical team members who manage chronic rhinosinusitis with nasal polyps. In this program, we will aim to discuss the burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach clinicians how to apply best practices for the interdisciplinary development of individualized treatment plans for these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach clinicians who manage this condition.
RELEASE DATE: March 11, 2022
EXPIRATION DATE: March 11, 2023
This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.
RELEASE DATE: March 11, 2022
EXPIRATION DATE: March 11, 2023
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder.
RELEASE DATE: March 16, 2022
EXPIRATION DATE: March 16, 2023
This enduring virtual activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of AD, impacting outcomes through identifying burdens affecting quality of life, assessing disease severity when considering topical vs systemic intervention, and utilizing strategies in shared decision-making when determining guideline-based care.
RELEASE DATE: March 28, 2022
EXPIRATION DATE: March 28, 2023
This enduring TeleECHO program will explore the management of ocular toxicities and other adverse events related to treatment of relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss how and why these adverse events occur. The importance of Risk Evaluation and Mitigation Strategy (REMS) programs for monitoring your patients for corneal changes and other effects of later-line therapy for multiple myeloma will also be presented. Interactive case studies will illustrate strategies for choosing therapy and for managing treatment-related adverse events in the RRMM setting.
RELEASE DATE: March 28, 2022
EXPIRATION DATE: March 28, 2023
RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023
The online activity will address renoprotective therapies in care of patients with T2D and CKD with a focus on mineralocorticoid receptor antagonists and SGLT2 inhibitors. Discussion will include mechanisms of action, emerging clinical data, best practices in screening patients, and management considerations for hyperkalemia.
RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023
This enduring TeleECHO activity will explore the use of JAK inhibitors for the management of rheumatoid arthritis (RA) through interactive case studies. Faculty will review emerging efficacy and safety data, discuss guideline recommended care of RA, and help clinicians identify candidates for treatment with JAK inhibitors.
RELEASE DATE: April 04, 2022
EXPIRATION DATE: April 04, 2023
This enduring activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of hepatorenal syndrome with acute kidney injury (HRS-AKI), impacting outcomes through diagnosis and differentiation from other forms of AKI as well as individualizing pharmacotherapeutic management.
RELEASE DATE: April 05, 2022
EXPIRATION DATE: April 05, 2023
This educational activity will explore the use of monoclonal antibodies for the treatment and prevention of COVID-19 in pediatric patients. A review of available clinical data will help clinicians identify candidates for therapy and select appropriate treatments based on the most up-to-date information.
RELEASE DATE: April 08, 2022
EXPIRATION DATE: April 08, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
In this episode, a pediatric infectious disease specialist will clarify when to use monoclonal antibodies in pediatric patients with COVID-19 and discuss ways to overcome challenges in administering therapy.
RELEASE DATE: April 11, 2022
EXPIRATION DATE: April 11, 2023
In this comprehensive and interactive CME activity, we will be presenting important topics in the area of diabetic kidney disease. The program includes slide-based material interspersed with interactive questions and case studies to enhance learning. The focus is on kidney disease in the diabetic patient, specifically mechanisms of disease, diagnosis and evaluation, and therapeutic options.
RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023
This enduring virtual activity targets healthcare gaps related to the treatment and management of AD in urban communities, impacting outcomes through identifying determinants that impact health in urban communities, implementing strategies in disease severity assessment across varying skin tones, and guideline-based care.
RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023
This interactive global educational activity is designed to help oncologists, pathologists, surgeons, dermatologists, and other healthcare practitioners who care for patients with advanced or metastatic basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC) to improve their knowledge of the disease, best practices for treatment, and the role of immunotherapy in managing non-melanoma skin cancer (NMSC).
RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023
In this program; we will aim to discuss the cost burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach pharmacists how to apply best practices within the framework of interdisciplinary managed care of these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach pharmacists who see this condition.
RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023
This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline recommended step-care management, and efficacy and safety of current and emerging biologic therapy.
RELEASE DATE: April 20, 2022
EXPIRATION DATE: April 20, 2023
The acute myeloid leukemia (AML) TeleECHO enduring program will explore strategies to promptly recognize, diagnose, and manage AML. This TeleECHO enduring provides a didactic programming in addition to case-based discussion on selecting therapeutic options and managing patients with AML.
RELEASE DATE: April 20, 2022
EXPIRATION DATE: April 20, 2023
This enduring TeleECHO educational series targets healthcare gaps related to the familiarity and understanding of CDK4/6 inhibitor clinical trial designs and results on efficacy, safety, and real-world studies, impacting outcomes through current practice patterns and treatment strategies in the management of HR+/HER2- metastatic breast cancer (mBC).
RELEASE DATE: May 04, 2022
EXPIRATION DATE: May 04, 2023
This enduring activity focuses on the treatment and management of cold agglutinin disease.
RELEASE DATE: April 28, 2022
EXPIRATION DATE: April 28, 2023
This case-based online enduring activity will cover the treatment and management of patients with Type 2 diabetes mellitus (T2D) who are at high risk for chronic kidney disease.
RELEASE DATE: April 28, 2022
EXPIRATION DATE: April 28, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
In this episode, an emergency medicine physician will discuss strategies for the administration of monoclonal antibodies in adult and pediatric patients in an emergency department setting.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
Oncology nurses are in an inherently valuable position to be in the frontline of breast cancer treatment for patients. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This educational activity will assess the pathophysiology and disease domains of psoriatic arthritis as well as review FDA-approved agents and their roles in in treating the disease. Additionally, we will discuss the appropriateness of combination or monotherapy regimens and unanswered questions in this area.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This enduring activity targets healthcare gaps related to the early intervention of retinal vascular diseases and familiarity with new and emerging clinical trial data, impacting outcomes through assessment and synthesis of clinical trial structures, and outcomes of studied anti-VEGF agents for incorporation into treatment strategy development.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This online activity will cover the pneumococcal vaccinations in specific populations.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This live virtual activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This enduring activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This activity provides a practice-based learning experience for medical oncologists, pulmonologists, nurse practitioners, and other health care providers, regarding the assessment and treatment of non-small cell lung cancer (NSCLC) in the first-line setting. By participating in this Simulation Center, learners will observe an interaction between a patient with NSCLC and their healthcare provider, and will test their knowledge of diagnosis and management at key decision points along the way.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
Pneumococcal disease caused by Streptococcus pneumoniae is the leading cause of pneumonia-related deaths and poses an important global public health concern. There are several vaccines available for prevention of this disease, but their implementation in the clinic is challenged by complex recommendations of their administration for various patient populations and by complicated guidelines for appropriate spacing and sequencing of vaccine schedules. Managed Care Specialists need to understand the nuances of pneumococcal vaccines to guide physicians on their appropriate use to reduce infections and improve clinical outcomes, particularly for at-risk patients. This educational activity will explore the impact of pneumococcal disease, pathophysiology of disease, guidelines recommendations, and strategies for managing vaccine hesitancy. In addition to a didactic presentation, the program features animations and case discussions to highlight the different aspects of this disease.
RELEASE DATE: May 10, 2022
EXPIRATION DATE: May 10, 2023
This program will discuss the nuances of EGFR-mutated non-small-cell lung cancer and the impact of genomic and metabolic pathways for treatment selection.
RELEASE DATE: May 11, 2022
EXPIRATION DATE: May 11, 2023
This online activity with an integrated case-based learning component will enable clinicians to recognize emerging targets in the management of anemia of chronic kidney disease (CKD) through an understanding of the underlying pathophysiology and clinical trials evaluating novel therapies. By integrating these data with the current standards of care in the management of anemia of CKD, clinicians will be better able to understand the role of multiple healthcare professionals in the management of this common complication of CKD. Additionally, the integrated case-based activity within this program will ensure that healthcare professionals can readily translate learnings to patient interactions, ensuring that patients and the healthcare team are aware fully aware of emerging therapeutic alternatives.
RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023
Through a series of informative lectures and podcast interviews, this educational series will target clinicians in the field of rheumatology who have patients with psoriatic arthritis. We will provide the latest information on clinical presentation, differential diagnosis, therapeutic targets, and clinical trial data on current and emerging therapies to help learners reduce both short- and long-term consequences of the disease.
RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023
This enduring activity will focus on the T-cell Immunoreceptor with Ig and ITIM Domains (TIGIT).
RELEASE DATE: May 20, 2022
EXPIRATION DATE: May 20, 2023
This enduring TeleECHO program will explore the role of real-world evidence in informing management decisions of elderly and frail patients with relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss prognostic features and key management considerations for the elderly and frail patient populations. A summary of clinical trial data and real world evidence to inform treatment selection in the first-line and relapse settings will also be presented. Interactive case studies will illustrate strategies for patient counseling and treatment selection in elderly and frail patients with RRMM.
RELEASE DATE: May 20, 2022
EXPIRATION DATE: May 20, 2023
This activity invites learners to experience a virtual world illustrating personalized therapy for advanced non-small cell lung cancer (NSCLC). It provides a unique opportunity for learning about checkpoint inhibitor mechanisms in NSCLC, important biomarkers used to guide clinical decisions, and immune-related adverse events.
RELEASE DATE: May 24, 2022
EXPIRATION DATE: May 24, 2023
This enduring activity covers the pathogenesis of Metastatic Castration-resistant Prostate Cancer (mCRPC) and which patients may benefit from using PARP Inhibitor–based Combinations.
RELEASE DATE: May 24, 2022
EXPIRATION DATE: May 24, 2023
This interactive online activity will explore the diagnosis and management of hypertrophic cardiomyopathy (HCM). A didactic presentation by expert faculty will review guideline recommendations and risk factors for complications, discuss pharmacologic and surgical treatment options, and examine clinical trial data on emerging agents. An animated case will allow learners to apply what they have learned in a simulated clinical encounter.
RELEASE DATE: May 26, 2022
EXPIRATION DATE: May 26, 2023
This activity will explore the management of patients with of newly diagnosed and relapsed/refractory acute myeloid leukemia (AML). This program will address the role of genetic and molecular markers in treatment selection as well as best practices for treatment of newly diagnosed, and relapsed/refractory, and secondary AML. A summary of approaches to TRAE recognition and mitigation will also be discussed.
RELEASE DATE: May 26, 2022
EXPIRATION DATE: May 26, 2023
This CME program has been designed for endocrinologists who treat patients with type 2 diabetes. It aims to help learners evaluate the impact of weight loss and timely treatment intensification in patients with T2DM on glycemic and metabolic outcomes, and to increase knowledge of the mechanism of emerging GIP/GLP-1 receptor agonists and their impact on glycemic outcomes and body weight in order to advantageously integrate them into clinical practice when available.
RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023
This CME program has been designed to provide participants with the knowledge necessary to simultaneously address weight management and glycemic control in patients with type 2 diabetes and obesity/overweight. Participants will gain a greater understanding of guidelines-recommended pharmaceutical and lifestyle management strategies, and learn how incretin therapies with beneficial impacts on glycemic outcomes and body weight can be integrated into clinical practice. In addition to viewing a faculty presentation of relevant clinical data and guidelines, learners will participate in Med Games, an engaging gamified learning activity featuring interactive quizzes and video case studies that provide the opportunity to make decisions about patient care and get immediate feedback.
RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023
This enduring activity has been designed for HCPs treating metastatic castration-resistant prostate cancer (mCRPC) to improve: knowledge of the mechanisms of action of PARP inhibitor–based combinations for the treatment of patients with mCRPC with or without DNA damage response (DDR) alterations; awareness of new clinical data on the efficacy, safety, and tolerability of emerging PARP inhibitor–based combinations with different mechanisms of action for the treatment of patients with mCRPC; and their ability to develop individualized management plans for patients with mCRPC with or without DDR alterations that include PARP inhibitor–based combinations if appropriate.
RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023
This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline-recommended step-care management, and efficacy and safety of current and emerging biologic therapy.
RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023
In this educational activity, expert faculty will discuss the use of approved and authorized treatments for the management of patients hospitalized with COVID-19. A review of clinical trial data on the efficacy and safety of therapeutic options and strategies for selecting therapy based on disease severity and clinical factors will allow clinicians to reduce the need for invasive ventilation and improve patient outcomes.
RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
RELEASE DATE: June 01, 2022
EXPIRATION DATE: June 01, 2023
This enduring activity will explore the diagnosis and management of NTM-LD. Whiteboard animations will identify common pitfalls that lead to delays in diagnosis and look at the mechanism of action of novel therapies for refractory disease. A case-based didactic lecture led by expert faculty will review guideline-recommended care, strategies to minimize adverse events, and clinical trial data on newer treatment options.
RELEASE DATE: June 01, 2022
EXPIRATION DATE: June 01, 2023
This case-based enduring activity will focus on the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis (EoE). Patients with EoE are often diagnosed after symptom onset, leading to greater chronic inflammation, and treatment plans are frequently not tailored to individual needs. This activity is intended to help healthcare professionals diagnose EoE earlier and provide individualized treatment based on guidelines, recent clinical data and patient characteristics.
RELEASE DATE: June 03, 2022
EXPIRATION DATE: June 03, 2023
This educational activity will review clinical trial data on the use of authorized therapies for the management of patients hospitalized with COVID-19 and explore strategies to incorporate these therapeutic options into clinical practice. This program includes a whiteboard animation on the role of inflammation in the pathophysiology of severe COVID-19 and the mechanism of action of available treatment options.
RELEASE DATE: June 07, 2022
EXPIRATION DATE: June 07, 2023
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder (NMOSD).
RELEASE DATE: June 08, 2022
EXPIRATION DATE: June 08, 2023
This online activity has been designed for primary care, emergency care, sports neurologists, headache neurologists, and other healthcare professionals involved in the management of people with acute and chronic post-concussion symptoms to help them in evaluating and treating patients by using a patient-centered approach. This activity includes a personal interview featuring a patient who has experienced concussion and is now living with post-concussion syndrome.
RELEASE DATE: June 13, 2022
EXPIRATION DATE: June 13, 2023
This enduring activity is designed to review the importance of chronic kidney disease (CKD) risk reduction in patients with T2D, how to evaluate opportunities to screen for CKD risk in patients with T2D and target reductions in albuminuria, the manageability of hyperkalemia and uniqueness of novel therapy, and key takeaways and practice changes.
RELEASE DATE: June 16, 2022
EXPIRATION DATE: June 16, 2023
This enduring activity will focus on the latest updates in the optimal management of cancer-associated venous thromboembolism (VTE) based on risk stratification, clinical trial data, and appropriate guideline-informed strategies to optimize clinical outcomes. This program will inform participants of the latest best practices as recommended by professional guidelines and will equip participants to integrate multidisciplinary care and shared decision-making in practice.
RELEASE DATE: June 20, 2022
EXPIRATION DATE: June 20, 2023
This enduring activity targets healthcare gaps related to awareness of health disparities in the prevention and treatment of ocular diseases and the importance of diverse representation within clinical trials and the ophthalmology workforce, impacting outcomes through assessing for factors that can contribute to disparities in vision health and strategies to overcome them.
RELEASE DATE: June 24, 2022
EXPIRATION DATE: June 24, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
In this episode, an emergency nurse will review how to administer monoclonal antibodies in patients with COVID-19 and best practices for monitoring for adverse reactions.
RELEASE DATE: June 27, 2022
EXPIRATION DATE: June 27, 2023
This case-based enduring activity is designed to provide clinicians with an overview of Short Bowel Syndrome and highlight its impact on patient quality of life.
RELEASE DATE: June 27, 2022
EXPIRATION DATE: June 27, 2023
This educational activity will explore best practices for the management of rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and juvenile idiopathic arthritis (JIA). Expert faculty will review the latest information on clinical presentation, treatment recommendations, and clinical trial data on available therapies to help learners reduce both short- and long-term consequences of disease. An innovative simulation center will allow clinicians to apply what they have learned in an interactive, animated case.
RELEASE DATE: June 27, 2022
EXPIRATION DATE: June 27, 2023
Oncology nurses are in an inherently valuable position to be in the frontline for treatment of HER2-positive solid tumors. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. For additional resources, please visit www.oncologynurse-ce.com.
RELEASE DATE: June 29, 2022
EXPIRATION DATE: June 29, 2023
This online activity is designed to increase HCPs recognition of metabolic pathways involved in the pathophysiology of Gaucher disease; confidence discussing clinical trial data supporting improved outcomes in Gaucher disease; understanding of the potential for treatment to modify outcomes in Gaucher disease; and understanding of shared decision-making best practices for long-term management of Gaucher disease.
RELEASE DATE: May 26, 2022
EXPIRATION DATE: May 26, 2023
This enduring activity has been designed to help dermatologists, pediatric dermatologists, primary care physicians, advanced practice providers (NPs and PAs) and other healthcare providers who are involved in the care and treatment of patients with atopic dermatitis to assess patients for physical and psychosocial burdens of AD; identify candidates for systemic therapies; better evaluate recent clinical trial data on the efficacy and safety of JAK inhibitors for the management of moderate-to-severe AD; and apply evidence-based approaches to manage moderate-to-severe AD and monitor for adverse events.
RELEASE DATE: July 12, 2022
EXPIRATION DATE: July 12, 2023
This activity will explore the management of patients with of treatment-naïve and relapsed/refractory chronic lymphocytic leukemia (CLL). This program will address approaches to individualize selection of therapy and the role of minimal residual disease (MRD) in monitoring treatment effectiveness. A summary of approaches to TRAE recognition and mitigation will also be addressed.
RELEASE DATE: July 07, 2022
EXPIRATION DATE: July 07, 2023
This podcast will explore the management of patients with metastatic colorectal cancer (mCRC). Faculty will review strategies on personalizing the selection of treatment options based on molecular testing; and discuss the management of adverse events with targeted treatments for BRAF V600-mutant mCRC.
RELEASE DATE: July 08, 2022
EXPIRATION DATE: July 08, 2023
This enduring series will discuss the recognition and management of CKD risk in patients with T2D.
RELEASE DATE: July 14, 2022
EXPIRATION DATE: July 14, 2023
This activity discusses the growing impact of dengue fever worldwide and strategies to mitigate its spread. Featured topics of this program include signs and symptoms of dengue fever and differential diagnoses, the lifecycle of a dengue infection, and clinical trial data of approved and emerging vaccines.
RELEASE DATE: July 18, 2022
EXPIRATION DATE: July 18, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
RELEASE DATE: July 19, 2022
EXPIRATION DATE: July 19, 2023
This Community Whiteboard ECHO Series and Online Enduring activity is designed to increase the multi-disciplinary oncology care team recognition of the role of targeted and bispecific antibodies in management of relapsed/refractory DLBCL; strengthen their understanding of clinical trial outcomes and adverse events with targeted and bispecific antibodies; and improve their awareness of multidisciplinary best practices for managing adverse events from targeted therapies.
RELEASE DATE: July 20, 2022
EXPIRATION DATE: July 20, 2023
This activity features education regarding hormone therapy for children and adolescents with growth hormone (GH) deficiency. The program will discuss the diagnosis of GH deficiency, challenges of currently available therapies, clinical data of emerging therapies, and strategies to personalize care for childhood growth hormone deficiency (CGHD).
RELEASE DATE: July 22, 2022
EXPIRATION DATE: July 22, 2023
This online program targets critical issues in diabetic retinopathy, including the importance of screening and early detection of retinopathy, how early treatment in retinopathy can help prevent progression to vision-threatening complications, and the advantageous impact of multidisciplinary management in the care of a retinopathy patient. Learn essential elements of screening, referral, and treatment, as well as core systemic factors affecting risk for both development and worsening of diabetic eye disease, which when optimized can help preserve vision in diabetes.
RELEASE DATE: July 27, 2022
EXPIRATION DATE: July 27, 2023
This case-based online activity is designed for retina specialists, ophthalmologists, primary care providers, optometrists, and other healthcare providers who manage patients with neovascular age-related macular degeneration and/or diabetic macular edema. The activity aims to improve treatment for patients who do not achieve optimal outcomes due to insufficient responses to therapy or insufficient adherence. In addition, it will elucidate the benefits and limitations of current therapeutic approaches, equip participants with strategies for improving the durability of treatment response in patients receiving intravitreal therapies, and provide education on new and emerging treatment strategies.
RELEASE DATE: July 28, 2022
EXPIRATION DATE: July 28, 2023
PODCAST ACTIVITY: These podcasts provide an up-to-date perspective on improving treatment for patients with neovascular age-related macular degeneration and/or diabetic macular edema who do not achieve optimal outcomes due to insufficient responses to therapy or insufficient adherence. This series of podcasts will elucidate the benefits and limitations of current therapeutic approaches for patients with nAMD or DME, equip participants with strategies for improving the durability of treatment response in patients receiving intravitreal therapies, and provide education on new and emerging treatment strategies.
RELEASE DATE: July 28, 2022
EXPIRATION DATE: July 28, 2023
This educational opportunity has been designed for nephrology fellows to ensure recognition of CKD risk in patients with T2D, understand novel strategies for modifying CKD risk, and review the risk of other chronic complications of T2D. We aim to evaluate current strategies for the management of CKD in T2D using novel therapeutic agents that modify long-term clinical outcomes, including third-generation mineralocorticoid antagonists; describe current disparities in CKD care in T2D and strategies for integrating novel strategies in practice, including third-generation mineralocorticoid antagonists; and lastly to summarize safety data with novel agents in the management of CKD in T2D, including best practices for managing hyperkalemia with novel mineralocorticoid antagonists.
RELEASE DATE: July 28, 2022
EXPIRATION DATE: July 28, 2023
This activity will explore emerging treatment options and novel management strategies of patients with relapsed/refractory MCL or CLL/SLL.
RELEASE DATE: August 03, 2022
EXPIRATION DATE: August 03, 2023
This simulated activity depicts conversations between an oncologist, a pathologist, and a patient diagnosed with non-small cell lung cancer (NSCLC). You will watch as they engage with each other throughout the various stages of a patient’s journey, from the initial pathologic and oncologic workup at initial presentation to disease recurrence. You will participate in the simulation by answering questions throughout the activity. A brief slide presentations is available within each simulation center activity to enhance your understanding of immunological biomarkers.
RELEASE DATE: August 04, 2022
EXPIRATION DATE: August 04, 2023
This enduring TeleECHO program will explore key clinical practice insights for management of patients with BRAF-mutated metastatic melanoma. Over the course of this activity there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Interactive case studies will illustrate strategies for treatment selection, mitigation of adverse events, and management considerations for patients with BRAF-mutated metastatic melanoma.
RELEASE DATE: August 11, 2022
EXPIRATION DATE: August 11, 2023
Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.
Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.
Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.
